The July 2026 certificate for BPC-157 20mg, lot PH-bc20-0526, shows the level of detail
Your Safety and Well-being Come First: We understand you may have concerns about starting a new medication, especially an injectable one: Side Effects: The most common side effects are gastrointestinal, such as nausea, vomiting, diarrhea, constipation, or abdominal pain
11.8% at 2.4 mg vs 2.3% placebo (68 wk) 9.5% to 20.1% across dose arms vs 0.4% placebo (48 wk) Tolerability signal Mostly gastrointestinal nausea, vomiting, diarrhoea, constipation
Featuring 4 patented ingredients clinically-studied to support natural GLP-1 production, satiety, fat metabolism and stable energy.
Were here to help every step of the way. Stay tuned for more in our GLP-1 series, where well explore other important facets of these medications: from side effects and mental health impacts, to long-term strategies and the future of weight loss management
A patient-friendly guide to semaglutide side effects, warning signs, and the blood tests that may help monitor glucose, kidney, liver, pancreatic, and nutritional health